Literature DB >> 7146320

Oxygenation of malignant tumors after localized microwave hyperthermia.

P W Vaupel, J Otte, R Manz.   

Abstract

The oxyhemoglobin saturation (HbO2) of single red blood cells within tumor microvessels (diameter: 3-12 micrometers) of DS-Carcinosarcoma was studied using a cryophotometric micromethod. In untreated control tumors (mean tissue temperature approx. 35 degrees C) the measured values scattered over the whole saturation range from zero to 100 sat. %, the mean being 51 sat. %. Upon heating at 40 degrees C for 30 min, the oxygenation of the tumor tissue significantly improved as compared with control conditions. After 40 degrees C-hyperthermia a mean oxyhemoglobin saturation of 66 sat. % was obtained. In contradistinction to this, after 43 degrees C-hyperthermia the tumor oxygenation was significantly lower and reached a mean HbO2 saturation value of 47 sat. %. A further temperature rise to 45 degrees C caused the oxygenation to drop drastically (mean oxyhemoglobin saturation value: 24 sat. %). This is due to a severe restriction of nutritive blood flow. The changes in tumor oxygenation after hyperthermia seem to be predominantly mediated through changes in tumor blood flow, including tumor microcirculation, which showed a similar temperature dependence. Metabolic effects probably play a minor role in the oxyhemoglobin saturation distribution within tumor microvessels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7146320     DOI: 10.1007/bf01323754

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  32 in total

1.  The examination of multicomponent systems in biological materials by means of a rapid scanning photometer.

Authors:  D W Lübbers; R Wodick
Journal:  Appl Opt       Date:  1969-05-01       Impact factor: 1.980

2.  Intracapillary HbO2 saturation in malignant tumors during normoxia and hyperoxia.

Authors:  P Vaupel; R Manz; W Müller-Klieser; W A Grunewald
Journal:  Microvasc Res       Date:  1979-03       Impact factor: 3.514

3.  Intracapillary hemoglobin oxygen saturation and oxygen consumption in different layers of the left ventricular myocardium.

Authors:  J Holtz; W A Grunewald; R Manz; W von Restorff; E Bassenge
Journal:  Pflugers Arch       Date:  1977-09-16       Impact factor: 3.657

4.  Temperature range and selective sensitivity of tumors to hyperthermia: a critical review.

Authors:  J A Dickson; S K Calderwood
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  Influence of pH on the thermal sensitivity of cultured human glioblastoma cells.

Authors:  L E Gerweck; B Richards
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

6.  Intracapillary HbO2 saturation in tumor tissue of DS-carcinosarcoma during normoxia.

Authors:  P Vaupel; W A Grunewald; R Manz; W Sowa
Journal:  Adv Exp Med Biol       Date:  1977 Jul 4-7       Impact factor: 2.622

Review 7.  Hyperthermic effects on animal tissues.

Authors:  H D Suit
Journal:  Radiology       Date:  1977-05       Impact factor: 11.105

8.  Circulatory and metabolic responses of malignant tumors during localized hyperthermia.

Authors:  P Vaupel; K Ostheimer; W Müller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  Blood flow in normal tissues and tumors during hyperthermia.

Authors:  C W Song; J G Rhee; S H Levitt
Journal:  J Natl Cancer Inst       Date:  1980-01       Impact factor: 13.506

10.  Alterations in tumor microvasculature during hyperthermia.

Authors:  H A Eddy
Journal:  Radiology       Date:  1980-11       Impact factor: 11.105

View more
  11 in total

1.  Rationale and indications for perfusion in liver tumors: current data.

Authors:  K Schwemmle; K H Link; B Rieck
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

2.  Tumour thermotolerance, a physiological phenomenon involving vessel normalisation.

Authors:  Ruud P M Dings; Melissa L Loren; Yan Zhang; Sterling Mikkelson; Kevin H Mayo; Peter Corry; Robert J Griffin
Journal:  Int J Hyperthermia       Date:  2011-01-04       Impact factor: 3.914

Review 3.  Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors.

Authors:  Robert J Griffin; Ruud P M Dings; Azemat Jamshidi-Parsian; Chang W Song
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

4.  Experimental evidence for a hyperthermia-induced breakdown of tumor blood flow during normoglycemia.

Authors:  P Vaupel; W Müller-Klieser; H Gabbert
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Tumour pO2 can be increased markedly by mild hyperthermia.

Authors:  K Iwata; A Shakil; W J Hur; C M Makepeace; R J Griffin; C W Song
Journal:  Br J Cancer Suppl       Date:  1996-07

6.  Laser Doppler flux and tissue oxygenation of experimental tumours upon local hyperthermia and/or hyperglycaemia.

Authors:  W K Mayer; M Stohrer; W Krüger; P Vaupel
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 7.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

8.  Microregional distributions of glucose, lactate, ATP and tissue pH in experimental tumours upon local hyperthermia and/or hyperglycaemia.

Authors:  C Schaefer; W K Mayer; W Krüger; P Vaupel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Acute changes of systemic parameters in tumour-bearing rats, and of tumour glucose, lactate, and ATP levels upon local hyperthermia and/or hyperglycaemia.

Authors:  W Krüger; W K Mayer; C Schaefer; M Stohrer; P Vaupel
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 10.  Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?

Authors:  Jan C Peeken; Peter Vaupel; Stephanie E Combs
Journal:  Front Oncol       Date:  2017-06-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.